Banner Occupational Health
Health Risk Assessment (HRA) with Blood Chemistry Panel and Blood Pressure Screening
The HRA Personal Wellness Profile is a measurement of one's current health status. It encourages individuals' awareness of those health needs and lifestyle practices that determine personal well-being. The individual report is combined with a Chem 24 blood chemistry panel to help participants evaluate their current lifestyle, identify health risks and learn where and how to make improvements. The Chem 24 Chemistry Panel includes the following measurements: cholesterol, HDL, LDL, triglycerides, risk ratio, iron, thyroid, and glucose, along with several heart, liver, kidney and muscle enzymes.
This health assessment will determine areas of health risk and/or interests for your employees. Individual reports will be sent to each participant. Executive summaries outlining overall company risk and group results will be presented to your management team. The executive and individual participant summaries will enable us to assist you in developing cost effective Wellness programs with the greatest impact for your employees.
Complete Blood Count (CBC)
A CBC is an aid to screen for many diseases and used by many physicians as a general check for wellness.
A CBC can test for things such as leukemia or anemia. It is also helpful when used with other tests to detect many medical problems, such as infections and to determine if an infection is bacterial or viral.
Prostate Specific Antigen (PSA) Blood Screening
This is an optional blood screening for men. The American Urological Association and the Prostate Cancer Education Council recommend annual prostate screenings for all men age 50 and over (earlier if positive family history).
Homocysteine is a new test that can be helpful in assessing the risk of heart attack, stroke, and dementia. It can also be used to determine Vitamin B12 deficiency and may be elevated in diseases of kidneys, thyroid, bowel, or alcoholism. This test is especially recommended for those with cardiovascular disease or a family history of early dementia.
High Sensitivity C-Reactive Protein (hsCRP)
High sensitivity (cardio) C-reactive protein is a new test that can be helpful in assessing the risk of heart attack and stroke. This sensitive test measure the presence of inflammation in the body. This has been implicated as one of the factors contributing to cardiovascular disease. This test, combined with a cholesterol screening, can aid physicians in the early diagnosis and treatment of heart disease. A physician is needed to accurately interpret the results of the test.
Hepatitis C Screening
Hepatitis C is a disease of the liver caused by the hepatitis C virus. Hepatitis C is one of six forms of hepatitis and is the most serious form. It currently affects over 4 million Americans. Most people with hepatitis C have no outward signs or symptoms. Others do experience "flu-like" symptoms, such as fatigue, loss of appetite, nausea and vomiting, fever, weakness and mild abdominal pain. Less common symptoms are dark urine and yellowing of the skin and eyes.
About 85 percent of all hepatitis C infections develop into chronic (long-term) disease. If left untreated, there is a chance of developing cirrhosis, liver failure, and liver cancer. Liver failure due to hepatitis C is now the leading cause of liver transplants in the United States.
We require that any individual interested in having the Hepatitis C Antibody blood test (Anti-HCV) participate in a brief educational session at the time of the blood draw.
Hepatitis C screening results are released to the participant only. Results released to employers will consist of statistics only, even if an employer is guarantor for payment of service.